Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |